Clinical Trials Logo

Clinical Trial Summary

To understand the benefits of the neurolens Measurement Device and neurolens treatment as it pertains to treating symptoms related to Convergence Insufficiency. It is a Prospective randomized double masked two arm performed on a minimum of 100 to a maximum of 150 subjects identified as symptomatic (CISS questionnaire score equal to or greater than 16) done across 3-10 clinical sites. There are two subgroups: a minimum of 50 in each subgroup(subgroup 1: pre-presbyopic (18-40 years); subgroup 2: presbyopic subjects(41-60 years).


Clinical Trial Description

This study is a two-arm crossover study with two subgroups. Subjects will initially be assessed for their convergence insufficiency symptoms (convergence insufficiency symptom score (CISS v-15) questionnaire) and then are provided an updated refractive prescription and will wear them for 35 ± 5 days. Symptoms will be reassessed after the 35-day control break in. If the subject's symptoms have subsided, they will be exited from the study and will keep their lenses. Provided the subject has symptoms (CISS questionnaire score ≥ 16) after their 35-day use of their updated prescription and they continue to meet the inclusion/exclusion criteria they will proceed to the evaluation portion of the protocol. The first arm receiving neurolens first and the second arm receiving the control first. The control is a single vision or PAL lens which yields the BCDVA and BCNVA of a test subject with no prismatic correction. The neurolens prescribed prism will be based on the practitioner's Rx using the subject's best response to a prism trial lens and must be within a half prism diopter of the neurolens value output of the neurolens Measurement Device and providing the subject's BCDVA and BCNVA. Participants will come back after 35 day wear of their first test lens and the symptom questionnaire is reassessed. They will be now be crossed over to the second pair of study lenses (i.e. subjects in the first arm will not receive control lens and the ones in the second arm will not receive neurolens).Participants will come back after 35 day wear of their second test lens and the symptom questionnaire is reassessed for the final time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05087563
Study type Interventional
Source Neurolens Inc.
Contact
Status Terminated
Phase N/A
Start date November 22, 2021
Completion date May 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03248336 - Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children N/A
Recruiting NCT05262361 - Persistent Post-Concussion Symptoms With Convergence Insufficiency N/A
Terminated NCT03123822 - Spectacles Lens in Concussed Kids N/A
Completed NCT00472407 - Screening for Convergence Insufficiency in School-age Children
Completed NCT00347945 - Randomized Trial of Treatments for Convergence Insufficiency Phase 3
Completed NCT05070767 - Neurolens Headache Study N/A
Completed NCT03319966 - Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Recruiting NCT04691427 - Effectiveness of Virtual Reality Vision Therapy - VERVE Early Phase 1
Completed NCT02607384 - The Baltimore Reading and Eye Disease Study N/A
Active, not recruiting NCT02207517 - Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency Phase 3
Completed NCT00347581 - A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children Phase 3
Recruiting NCT05603962 - The Effectiveness of Visual Training in Convergence Insufficiency Patients N/A
Completed NCT01515943 - Convergence Insufficiency Treatment Study (CITS) N/A
Recruiting NCT05877560 - Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency N/A
Recruiting NCT05948046 - The Health-Related Quality of Life of the Patients With Symptomatic Convergence Insufficiency
Active, not recruiting NCT00338611 - Convergence Insufficiency Treatment Trial (CITT) Phase 3
Recruiting NCT05012384 - Effect of Vergence Exercises for Patients With Convergence Insufficiency After Concussion. N/A
Recruiting NCT05761106 - Effect of Exercises on Convergence Insufficiency in Individuals With Temporomandibular Disorders N/A
Completed NCT02510040 - A Prospective Observational Study of Adult Strabismus
Recruiting NCT05311917 - Home Vision Therapy and Prism Prescription in Presbyopic Persons With Convergence Insufficiency N/A